Journal of Virology · 2019 · 28 citations · 40 references
Life SciencesInfectious DiseasesMolecular BiologyMolecular VirologyVaccinologyVirologyAntiviral TherapyRna-protein InteractionsViral Gene ExpressionViral HepatitisViral Hepatitis TreatmentViral Rna BiologyAntiviral TherapeuticsFulminant Viral HepatitisHepatitis B Virus ReplicationLiver Fibrosis ProgressionRna Virus BiologyRna-binding MotifViral Hepatitis PathogenesisViral Rna Packaging
Hepatitis B virus (HBV) is a ubiquitous human pathogen, and HBV infection is a major global health burden. Chronic HBV infection is associated with the development of liver diseases, including fulminant hepatitis, hepatic fibrosis, cirrhosis, and hepatocellular carcinoma. A currently approved vaccine can prevent HBV infection, and medications are able to reduce viral loads and prevent liver disease progression. However, current treatments rarely achieve a cure for chronic infection. Thus, it is important to gain insight into the mechanisms of HBV replication. In this study, we found that the host factor RBM24 is involved in pregenomic RNA (pgRNA) packaging and regulates HBV replication. These findings highlight a potential target for antiviral therapeutics of HBV infection.
40
Imaging individual mRNA molecules using multiple singly labeled probes
Arjun Raj, Patrick van den Bogaard, Scott A. Rifkin et al. · Nature Methods · 2008 · 2.2K citations · Full text
Stephanie K. Ladner, Michaël Otto, Christopher S. Barker et al. · Antimicrobial Agents and Chemotherapy · 1997 · 635 citations · Full text
Up‐regulated long non‐coding RNA H19 contributes to proliferation of gastric cancer cells
Jianwei Bi, Xuchao Xue, Luming Zheng et al. · FEBS Journal · 2012 · 491 citations · Full text